ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Salmon Heads AACI, Owens President Elect; AMA Adds PDQ To Its Electronic Network

June 30, 1989

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979